A B S T R A C T The present study was undertaken to investigate the mechanism whereby alpha adrenergic stimulation with intravenous norepinephrine results in a water diuresis. Renal perfusion pressure was kept constant in all experiments by adjustment of a suprarenal aortic clamp. In hydropenic anesthetized dogs the intravenous infusion of norepinephrine (0.5 /g/kg per min) was associated with a mean decrease in urinary osmolality from 616 to 126 mosmol/kg (P < 0.001) which increased to 532 mosmol/kg (P < 0.001) after the infusion was discontinued. During the same period of time the mean free water clearance increased from -0.437 to 1.59 (P < 0.001) and then returned to -0.314 ml/min (P <0.001) after cessation of the infusion. This diuretic effect occurred in both innervated and denervated kidneys and was not ing 20-30 AU/kg per min of vasopressin. These results thus indicate that the water diuresis associated with intravenous norepinephrine is mediated primarily by suppression of vasopressin release rather than by changes in renal hemodynamics, renal innervation, or an effect of norepinephrine on the water permeability of the tubular epithelium.
INTRODUCTION
The results of several previous investigations indicate that alpha adrenergic stimulation with the endogenous catecholamine, norepinephrine, is associated with an increase in the renal excretion of solute-free water (1) (2) (3) (4) (5) . The mechanism for this diuretic effect, however, is not known. In earlier studies suppression of endogenous vasopressin release was proposed as the mechanism (1) and more recently an interrelationship between vasopressin (ADH) 1 and norepinephrine at the cellular level of the renal tubular epithelium has been suggested (3) (4) (5) . The latter hypothesis has been considered attractive since the effect of vasopressin appears to be mediated by stimulating adenyl cyclase to catalyze the formation of 3',5'-adenosine monophosphate (cyclic AMP) (6) (7) (8) , a process which has been shown to be inhibited by alpha adrenergic stimulation in several tissues of the body (9) (10) . Support for this hypothesis is obtained from the observation that the effect of norepinephrine to produce a water diuresis may occur in the absence of increases in either solute excretion rate or glomerular filtration rate (1) (2) (3) . Moreover, Strauch and Langdon (11) and Handler, Bensinger, and Orloff (12) have found that norepinephrine antago-nizes the in vitro effect of ADH on water transport by the toad bladder.
A consideration of the previous in vivo studies (1) (2) (3) (4) (5) , however, does not allow a definitive conclusion that alpha adrenergic stimulation with norepinephrine exerts a direct effect on the water permeability of the renal tubular epithelium. In all of these previous experiments (1) (2) (3) (4) (5) the increase in renal arterial pressure which occurred during the intravenous administration of norepinephrine may have been responsible for the observed water diuresis (13, 14) . In addition, alterations in systemic hemodynamics during the norepinephrine administration, such as changes in cardiac output, total peripheral resistance, and systemic arterial pressure, may have led to a suppression of vasopressin release. Somewhat against a suppression of vasopressin release accounting for the diuretic effect of norepinephrine is the finding that this effect has been observed during the infusion of exogenous vasopressin (3, 5) . Submaximal doses of vasopressin were, however, used in these previous studies and no evidence was provided that maximal suppression of endogenous ADH was present at the time that the norepinephrine was infused (3, 5) .
On the background of these in vivo studies (1) (2) (3) (4) (5) , the present investigation was undertaken to examine the mechanisms of the diuretic effect of alpha adrenergic stimulation with norepinephrine and in particular to differentiate between a direct effect on the wvater pernmeability of the renal tubule, an effect mediated by alterations in renal arterial pressure or other renal hemodynamics, and an effect mediated by an extrarenal mechanism involving suppression of the release of ADH.
The results demonstrated that the diuretic effect of norepinephrine may occur in experiments in which the renal arterial pressure is maintained constant. This enhanced rate of water excretion was not associated with either an increase in glomerular filtration rate or solute excretion rate and was unaltered by renal denervation. However, neither the intravenous nor the intrarenal administration of norepinephrine was associated with a water diuresis in acutely hypophysectomized animals receiving an exogenous infusion of vasopressin. On the basis of these results, we therefore conclude that the major effect of alpha adrenergic stimulation with norepinephrine to enhance the renal excretion of solute-free water is mediated by an extrarenal mechanism involving the suppression of endogenous ADH rather than a direct effect on the water permeability of the tubular epithelium or an indirect effect related to an increase in renal arterial pressure, glomerular filtration rate, or solute excretion.
METHODS 33 experiments were performed in 22 mongrel dogs of either sex weighing [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] kg. Food was withheld 18 h before study but water was allowed ad lib. On the morning of study the animals were anesthetized with intravenous pentobarbital (30 mg/kg), intubated, and ventilated with a Harvard respirator (Harvard Apparatus Co., Millis, Mass.). Light anesthesia was maintained throughout the experiment by the administration of pentobarbital. After induction of anesthesia all animals received 5 mg of deoxycorticosterone acetate in oil intramuscularly. In 17 animals acute hypophysectomy was performed through a buccal approach, after which these animals received 0.8 mg of dexamethasone both intramuscularly and intravenously. In all animals polyethylene catheters were placed in both ureters and renal veins through bilateral flank incisions using a retroperitoneal approach. Denervation of kidneys was performed by stripping and severing the renal nerves from the renal pedicle and then applying 95% alcohol to the renal pedicle. In most animals, an adjustable Blalock clamp was placed around the aorta above the origin of both renal arteries through the left flank incision. Catheters were placed in the aorta via the brachial and femoral artery for continuous measurement of arterial pressure above and below the aortic clamp, and into the vena cava from the femoral vein for continuous measurement of venous pressure. Both arterial and venous pressures were measured using Statham transducers (Statham Instruments, Inc., Oxnard, Calif.) and a direct writing Gilson recorder (Gilson Medical Electronics, Inc., Middleton, Wis.). A catheter was also placed into the right atrium via the jugular vein to inject indocyanine green dye for determination of cardiac output by the dye dilution method using methods and instruments as previously described (15) . After completion of the surgery, an intravenous infusion of 2.5 g/100 ml glucose (0.5 ml/min) was started which contained sufficient inulin and paraaminohippuric acid (PAH) to maintain blood levels of these substances between 15 and 25, and 1 and 3 mg/100 ml, respectively. Both of these infusions were continued throughout the experiments. The experiments were not started until at least 1-2 h after commencing the infusions and after stabilization of urine flow had occurred. Throughout the experiment urine was collected separately from each kidney at 10 to 20-min intervals and arterial and renal venous blood samples were collected at the midpoint of alternate collections of urine. In two hypophysectomized animals the right kidney was lost because of surgical mishap during the insertion of the renal vein catheter so that urine collections were only made from the left kidney. Cardiac output measurements were made every third period during the experiment. The following four groups of experiments were performed.
Group I, intraventous itorepinephrine in intact dogs. After three to five control periods 1-norepinephrine bitartrate (0.5 Ag/kg per min) was infused intravenously and after a 30 min equilibration period three to five experimental periods were collected. The infusion of norepinephrine was then discontinued and after another 30 min equilibration period three to five postcontrol periods were collected. In all of the experiments, the renal perfusion pressure was maintained at the control level during the infusion of norepinephrine by adjustment of a suprarenal aortic clamp.
Group II, intravenous uiorepinephriuic in acutely hypophysectomized dogs receiving 80 tLU/kg per mmin of vasopressin (Pitressin, 20 USP pressor U/ntl). After completion of the surgery in these animals an infusion of 0.9% sodium chloride containing exogenous vasopressin (80 ,uU/kg per min) was started at 0.5 ml/min. This dose was chosen after preliminary experiments demonstrated that this amount of exogenous vasopressin would produce a range of urinary os- molalities in the hypophysectomized dogs which was comparable with the range of urinary osmolalities in the intact dogs (group I). The protocol was otherwise identical with that used in the group I experiments. Group III, intravenous norepinephrine in acutely hypophysectomized dogs receiving 20-40 ,u U/kg per min of vasopressin. These studies were performed to investigate whether an effect of intravenous norepinephrine to inhibit the action of vasopressin is demonstrable only at low doses of vasopressin. The protocol in these experiments was otherwise identical with that used in the group II experiments.
Group IV, infusion of norepinephrine (0.05-0.06 IAU/kg per min) into the renal artery of hypophysectomized dogs receiving 20-30 1LU/kg per min of vasopressin. These studies were performed to examine whether an amount of norepinephrine, which is equal to or greater than the amount of norepinephrine estimated to reach the kidney during the intravenous norepinephrine studies (group I), is associated with an effect on renal water excretion. With the exception that the norepinephrine was infused through a The analytical procedures and calculations used in the present experiments have been referred to elsewhere (16) . The following abbreviations will be used: glomerular filtration rate (GFR), renal vascular resistance (RVR), filtration fraction (FF), free water clearance (CHso) and urinary osmolality (Uosm). The student paired t test was used for statistical analysis of results obtained in the same animal and the unpaired t test was used for analysis of results in different groups of animals. A P value <0.05 was considered significant.
RESULTS
Group I, effects of intravenous norepinephrine (NE) in hydropenic dogs ( Fig. 1 , Table I ). The results in group I, as well as groups II-IV, were not significantly different in the innervated and denervated kidneys therefore the results of all the kidneys have been ana- 1) . The mean Uosm decreased from 616±89 SEM to 126±13 mosmol/kg (P < 0.001) with the NE infusion and increased to 532 mosmol/kg H20 (P < 0.001) after cessation of the infusion. At the same time, the mean CH2O increased from -0.44+0.1 to 1.59 ml/min (P < 0.001) with the infusion of NE and decreased to -0.31 ml/min (P < 0.001) after cessation of the infusion. This effect of NE to increase renal water excretion was associated with a mean rise in arterial pressure from 121±7.8 to 142±6.6 mm Hg (P < 0.005) which decreased to 117±8.4 mm Hg (P < 0.005) after cessation of the infusion. Although this rise in arterial pressure was primarily due to an increase in total peripheral resistance, cardiac output did increase in four of six experiments in which it was measured. This effect was, however, not statistically significant. The infusion of NE was associated with a small but significant increase in hematocrit which returned to control level after the infusion was stopped. The diuretic effect of intravenous NE was not associated with significant alterations in renal hemodynamics or solute excretion. Mean GFR was 49.6+2.9, 50.3+3.1, and 53.5±3.2 ml/min before, during, and after the infusion of NE, respectively, as RVR was 0.495±0.05, 0.495+0.06, and 0.439±0.05 mm Hg ml/min. Although FF was not significantly changed during the infusion (0.331±0.01 to 0.348±0.02), there was a significant fall in FF to 0.315±0.01 (P < 0.025) after cessation of the infusion. Neither sodium nor potassium excretion increased significantly during the infusion of NE but there was a significant increase in sodium excretion after cessation of the infusion.
Group II, effects of intravenous NE in hypophysectomized dogs receiving 80 ,gU/kg per min of vasopressin (Fig. 2 , Table II ). The intravenous infusion of NE in the hypophysectomized dog receiving 80 iAU/kg per min vasopressin was not associated with either a decrease in Uosm or an increase in CH2o (Fig. 2) . The mean U03m was 1039±117 before, 1019+96 during, and 1053±78 mosmol/kg H20 after the NE infusion, as CH20 was -0.39+0.04, -0.36+0.03, and -0.41±0.05 ml/min, respectively. This absence of a diuretic effect of NE in these studies was observed over a wide range of control Uosm (range: 385-2232 mosmol/kg H20). Although intravenous NE failed to produce a water diuresis in these hypophysectomized dogs, the effects on systemic and renal hemodynamics were quite similar to those observed during the NE infusion in the intact hydropenic dog. The intravenous infusion of NE was not associated with a significant change in cardiac output (3.4±0.4 to 3.5±0.4 liters/min) but cardiac output decreased significantly to 2.9±0.3 liters/min (P < 0.02) after cessation of the infusion. Systemic arterial pressure increased from 111±4.7 to 149±5.5 mm Hg (P < 0.001) during the NE infusion and diminished to 103±5.4 mm Hg with cessation of the infusion (P < 0.001). Renal perfusion pressure was kept constant at 107±4.7 during the NE infusion but diminished to 98±3.3 mm Hg (P < 0.05) after the infusion was stopped. As in the intact animals, the NE infusion was associated with a modest but consistent increase in hematocrit. GFR and RVR were not significantly altered by the NE infusion but a reversible increase in FF was observed. The NE infusion was associated with a small but significant decrease in both sodium and potassium excretion.
Group III, effects of intravenous NE in hypophysectomized dogs receiving 20-40 msTU/kg per min of vasopressin (Fig. 3 , Table III ). The intravenous infusion of NE in the hypophysectomized dogs receiving 20-40 stimulating properties of the hormone. Although norepinephrine stimulates both alpha and beta adrenergic receptors, the diuretic effect of norepinephrine has been found to be abolished by alpha but not beta adrenergic blockade (4, 5) . Moreover, beta adrenergic stimulation with intravenous isoproterenol is associated with an antidiuretic rather than a diuretic effect (17) . The mechanism whereby alpha adrenergic stimulation increases renal water excretion, however, is not clearly understood. The increase in systemic and renal arterial pressure which occurs during the intravenous infusion of norepinephrine could account for this diuretic effect (13-14). However, in present experiments the renal perfusion pressure was kept constant, and yet the intravenous infusion of norepinephrine was consistently associated with an increase in renal water excretion. The enhanced water excretion during the intravenous norepinephrine infusion was also not associated with either a significant increase in glomerular filtration rate or solute excretion rate and was not abolished by renal denervation. These findings, therefore, suggested that the effect of norepinephrine to increase solute-free water excretion might be mediated by either an antagonism of the action of vasopressin or by a suppression of release of endogenous vasopressin. The latter mechanism was possible since the dose of intravenous norepinephrine which was used in the present and previous studies is associated with an increase in total peripheral resistance and in systemic arterial pressure (1) (2) (3) (4) (5) . Although, in the present experiments renal arterial pressure was kept constant by adjustment of a suprarenal aortic clamp the systemic arterial pressure above the clamp, and in particular in the cerebral circulation, was increased. This increase in arterial pressure, or some consequence thereof, could have diminished the release of vasopressin and thereby accounted for the observed diuretic effect. This possibility was examined by investigating whether intravenous norepinephrine is associated with pressure, however, were not excluded as factors in the observed water diuresis in this previous study (3) . We, therefore, undertook studies to examine whether intravenous norepinephrine was associated with a water diuresis in hypophysectomized dogs receiving low doses of vasopressin jg/kg per min). This dose of vasopressin is in the same range as that used in a previous study in the dog in which intravenous norepinephrine was demonstrated to be associated with a water diuresis (5) . In this previous investigation, however, renal perfusion pressure was allowed to increase during the intravenous infusion of norepinephrine. Maximal suppression of endogenous vasopressin also may not have been present before the norepinephrine infusion since the control urinary osmolalities were in a range compatible with the presence of some endogenous vasopressin (150-170 mosmol/kg) (5) . After acute hypophysectomy in the present group III animals the mean urinary osmolality was 87 mosmol/kg before starting the administration of the low dose of vasopressin. After the vasopressin administration the mean urinary osmolality of 238 mosmol/kg was significantly below the mean urinary osmolality in either the intact dogs (group I) or the hypophysectomized dogs receiving higher doses of exogenous vasopressin (group II). In these group III studies, as in the group II studies, the intravenous infusion of norepinephrine was not associated with a significant alteration in urinary osmolality or free water clearance (Fig. 3) . These results thus further support the conclusion that suppression of endogenous vasopressin is the primary mechanism whereby the intravenous infusion of norepinephrine is associated with a water diuresis. This finding that alpha adrenergic stimulation may suppress vasopressin release does not exclude an additional competive effect of norepinephrine on the action of vasopressin particularly with larger doses of the catecholamine as may be used in in vitro studies. It does, however, seem likely that the previous effects of norepinephrine on renal water excretion, in which the doses of norepinephrine per body weight were similar to that used in the present study, were primarily related to suppression of endogenous vasopressin and/or increases in renal perfusion pressure (1) (2) (3) (4) (5) . In the present group IV studies a dose of norepinephrine was infused into the renal artery in an amount estimated to exceed that reaching the kidney during the intravenous studies, and yet in a dose not causing a degree of renal vasoconstriction that would obscure any effect of norepinephrine to antagonize the action of vasopressin on the water permeability of the tubular epithelium. In these studies a small diminution in mean urinary osmolality was observed in the infused kidney but this effect was neither consistent nor statistically significant. Thus, a modest inhibition of the action of vasopressin by norepinephrine cannot be excluded but the conclusive demonstration of such an effect may not be possible in in vivo experiments.
There are several potential mechanisms whereby alpha adrenergic stimulation with intravenous norepinephrine may be associated with a suppression of endogenous vasopressin. Some authors (21) have suggested that catecholamines may directly suppress the release of vasopressin. While the results of recent investigations suggest that the effect of isoproterenol (17) and prostaglandin (22) on vasopressin release is mediated indirectly as a consequence of alterations in systemic hemodynamics, the present results do not exclude a direct central effect of norepinephrine on vasopressin release. Alternatively, however, the increase in systemic arterial pressure which occurred during the intravenous infusion of norepinephrine could have caused a suppression of vasopressin release or initiated a reflex which in turn led to a diminution in vasopressin release. In regards to the latter possibility, an increase in systemic arterial pressure might be expected to increase parasympathetic afferent vagal tone and thereby suppress vasopressin release. (24, 25) , a role of angiotensin in the diuretic effect of norepinephrine seems unlikely since existing evidence suggests that angiotensin stimulates rather than suppresses vasopressin release (26) . Taken together then with other recently published results from our laboratory (17, 22, 
